EVALUATION OF EZENUS IN AN EXPERIMENTAL MODEL OF DIET-INDUCED ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER CONDITION IN RATS
Keywords:
Ezenus, Andrographis paniculata, Boerhaavia diffusa, Vitis vinifera, Liver toxicity, Stress, Adaptogen, SteatohepatitisAbstract
Objective: Alcoholic and non-alcoholic fatty liver disease are found to affect more than 10% of the general population. Fatty liver condition in humans is directly correlated with psychosocial stress. Herbal formulations for the management of stress may present an alternative for the treatment of fatty liver disease. Ezenus is a polyherbal candy containing herbs that can ameliorate stress and consequent liver abnormality. The present study aimed to evaluate the effect of Ezenus in experimentally induced alcoholic and non-acloholic fatty liver condition.
Methods: Two models were studied simultaneously, prophylactic and therapeutic. Prophylactic groups received Ezenus along with fatty diet whereas the therapeutic groups received Ezenus only after induction of alcoholic or non-alcoholic fatty liver condition. Biochemical parameters were estimated in the serum on Days 0, 45 and 90. Lipid biochemistry of liver and histopathology were performed after terminal necropsy.
Results: Fatty liver condition was induced in rats within 45 days of fatty diet administration with or without alcohol. Results of the present study suggested that prophylactic administration of Ezenus prevented the development of fatty liver condition in rats to a certain extent. Therapeutic intervention with Ezenus after fatty diet intake for 45 days was able to prevent the deranging effects of fatty liver disease. This beneficial effect of Ezenus was attributed to the adaptogenic and antioxidant effects of the ingredients present in Ezenus.
Conclusion: Based on the results of the study, it was concluded that long term treatment of Ezenus exhibits a preventive effect in fatty liver disease. It not only protects the liver from toxic insults to a certain extent but also has the capability of maintaining the normal liver function.
Â
Downloads
References
Sheila-Sherlock D. Alcoholic liver disease. Lancet 1995;345:227-9.
Teli MR, Day CP, James OFW, Burt AD, Bennett MK. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-90.
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatol 2006;43 Suppl 1:S99-S112.
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of nonâ€alcoholic fatty liver disease and nonâ€alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-85.
Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. Brit Med J 2014;349:g4596.
Jansen PL. Non-alcoholic steatohepatitis. Eur J Gastroenterol Hepatol 2004;16:1079-85.
Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, Aging and involvement of oxidative stress. Pathways 2014;57:58.
Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-12.
Roingeard P. Hepatitis C virus diversity and hepatic steatosis. J Viral Hepat 2013;20:77-84.
Canbakan B, Tahan V, Balci H, Hatemi I, Erer B, Ozbay G, et al. Leptin in nonalcoholic fatty liver disease. Ann Hepatol 2008;7:249-54.
Blanchard OL, Smoliga JM. Translating dosages from animal models to human clinical trials—revisiting body surface area scaling. FASEB J 2015;fj.14-269043. [Epub ahead of print]
Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr 2006;25:816-23.
Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:663-78.
Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol 2014;20(7):1712.
Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biol Med 2012;52:59-69.
Orhan DD, Orhan N, Ergun E, Ergun F. Hepatoprotective effect of Vitis vinifera L. leaves on carbon tetrachloride-induced acute liver damage in rats. J Ethnopharmacol 2007;112:145-51.
Singh RP, Banerjee S, Rao AR. Modulatory influence of Andrographis paniculata on mouse hepatic and extrahepatic carcinogen metabolizing enzymes and antioxidant status. Phytother Res 2001;15:382-90.
Chiou A, Panagopoulou EA, Gatzali F, De Marchi S, Karathanos VT. Anthocyanins content and antioxidant capacity of Corinthian currants (Vitis vinifera L. var. Apyrena). Food Chem 2014;146:157-65.
Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060-6.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
Charatcharoenwitthaya P, Lindor KD, Angulo P. The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease. Dig Dis Sci 2012;57:1925-31.
Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 2012;15:665-74.
Khandelwal VKM, Balaraman R, Pancza D, Ravingerová T. Hemidesmus indicus and Hibiscus rosa-sinensis affect ischemia reperfusion injury in isolated rat hearts. Evidence-Based Complementary Altern Med 2011;8(1):1-8.
Khandelwal VKM, Balaraman R, Ondrejcáková M, Pancza D, Ravingerová T. Effect of Hemidesmus indicus on ischemia-reperfusion injury in the isolated rat heart. Pharm Biol 2010;48:611-4.
Gregory M, Khandelwal VKM, Mary RA, Kalaichelvan VK, Palanivel V. Barringtonia acutangula improves the biochemical parameters in diabetic rats. Chin J Nat Med 2014;12:126-30.
Khandelwal VKM, Koneri R, Balaraman R, Kandhavelu M. Biological activities of some indian medicinal plants. J Adv Pharm Educ Res 2011;1:12-44.